{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:43:03Z","timestamp":1792568583407,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Regeneron Pharmaceuticals, Inc."},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"DOI":"10.1007\/s40120-026-01058-z","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:22:24Z","timestamp":1792567344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Holistic Patient-Relevant Measurement in Amyotrophic Lateral Sclerosis: A Mixed-Methods Content Validity and Exploratory Rasch Analysis of Selected Clinical Outcome Assessments"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-6476","authenticated-orcid":false,"given":"William B.","family":"Nowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"McGale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Przydzial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cleanthous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsy A.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rofail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"Suppl 2","key":"1058_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/21678421.2025.2564561","volume":"26","author":"WB Nowell","year":"2025","unstructured":"Nowell WB, McGale N, Levy O, Heinrich P, Patel N, Andrews JA, et al. COG-04: patient-relevant measurement in amyotrophic lateral sclerosis: a mixed-methods study of selected clinical outcome assessments. Amyotroph Lateral Scler. 2025;26(Suppl 2):226. https:\/\/doi.org\/10.1080\/21678421.2025.2564561.","journal-title":"Amyotroph Lateral Scler"},{"issue":"Suppl 15","key":"1058_CR2","first-page":"S320","volume":"24","author":"D Hulisz","year":"2018","unstructured":"Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24(Suppl 15):S320\u20136.","journal-title":"Am J Manag Care"},{"issue":"18","key":"1058_CR3","doi-asserted-by":"publisher","first-page":"9966","DOI":"10.3390\/ijms25189966","volume":"25","author":"RE Rizea","year":"2024","unstructured":"Rizea RE, Corlatescu AD, Costin HP, Dumitru A, Ciurea AV. Understanding amyotrophic lateral sclerosis: pathophysiology, diagnosis, and therapeutic advances. Int J Mol Sci. 2024;25(18):9966.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1058_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-021-00250-5","volume":"10","author":"X Xu","year":"2021","unstructured":"Xu X, Shen D, Gao Y, Zhou Q, Ni Y, Meng H, et al. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed? Transl Neurodegener. 2021;10(1):29.","journal-title":"Transl Neurodegener"},{"issue":"11","key":"1058_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112616","volume":"20","author":"N Nowicka","year":"2019","unstructured":"Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J. Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci. 2019;20(11):2616.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1058_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","volume":"17","author":"GBD 2016 Motor Neuron Disease Collaborators","year":"2018","unstructured":"GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1083\u201397.","journal-title":"Lancet Neurol"},{"key":"1058_CR7","unstructured":"US Food and Drug Administration. Patient-focused drug development: Selecting, developing, or modifying fit-for-purpose clinical outcome assessments. 2022. Updated October 23, 2025. https:\/\/www.fda.gov\/media\/159500\/download."},{"issue":"4","key":"1058_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s40120-025-00740-y","volume":"14","author":"D Rofail","year":"2025","unstructured":"Rofail D, Chladek M, Williams B, Patel N, Nowell WB, Karantzoulis S, et al. Advancing future amyotrophic lateral sclerosis medicines by incorporating the patient voice into patient-centered holistic measurement strategies for clinical and real-world studies: results from targeted literature reviews. Neurol Ther. 2025;14(4):1311\u201343.","journal-title":"Neurol Ther"},{"issue":"1\u20132","key":"1058_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1\u20132):13\u201321.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1058_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jamaneurol.2019.4490","volume":"77","author":"CN Fournier","year":"2020","unstructured":"Fournier CN, Bedlack R, Quinn C, Russell J, Beckwith D, Kaminski KH, et al. Development and validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS). JAMA Neurol. 2020;77(4):480\u20138.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1058_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.70.1.70","volume":"70","author":"C Jenkinson","year":"2001","unstructured":"Jenkinson C, Fitzpatrick R. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry. 2001;70(1):70\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40120-026-00895-2","volume":"15","author":"WB Nowell","year":"2026","unstructured":"Nowell WB, McGale N, Levy O, Wilding S, Heinrich P, Patel NC, et al. Exploring the lived experiences of individuals with amyotrophic lateral sclerosis (ALS): a qualitative study and conceptual model of signs, symptoms, and functional impacts. Neurol Ther. 2026;15:1043\u201364.","journal-title":"Neurol Ther"},{"key":"1058_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1477-7525-9-101","volume":"9","author":"CJ Gibbons","year":"2011","unstructured":"Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). Health Qual Life Outcomes. 2011;9:101.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"1058_CR14","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s11136-024-03773-2","volume":"33","author":"M O'Connor","year":"2024","unstructured":"O\u2019Connor M, Broderick L, Lauher-Charest M, Waldman LT, Jackson K, Kosinski M, et al. A framework for best practices in clinical outcome assessment (COA) concept mapping: a case study. Qual Life Res. 2024;33(11):2941\u20138.","journal-title":"Qual Life Res"},{"key":"1058_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"1058_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"1058_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/qup0000145","volume":"8","author":"J Wright","year":"2021","unstructured":"Wright J, Moghaddam N, Dawson DL. Cognitive interviewing in patient-reported outcome measures: a systematic review of methodological processes. Qual Psychol. 2021;8(1):2\u201329.","journal-title":"Qual Psychol"},{"issue":"4","key":"1058_CR18","first-page":"2526","volume":"29","author":"NH Azizan","year":"2020","unstructured":"Azizan NH, Mahmud Z, Rambli A. Rasch rating scale item estimates using maximum likelihood approach: effects of sample size on the accuracy and bias of the estimates. Int J Adv Sci Technol. 2020;29(4):2526\u201331.","journal-title":"Int J Adv Sci Technol"},{"key":"1058_CR19","first-page":"59","volume-title":"Applications of latent trait and latent class models in the social sciences","author":"D Andrich","year":"1997","unstructured":"Andrich D, de Jong JHAL, Sheridan BE. Diagnostic opportunities with the Rasch model for ordered response categories. In: Rost J, Langeheine R, editors. Applications of latent trait and latent class models in the social sciences. Munster: Waxmann Verlag GmbH; 1997. p. 59\u201370."},{"key":"1058_CR20","unstructured":"Andrich D, Sheridan B. RUMM 2030. Perth (WA): RUMM Laboratory Pty Ltd; 1997\u20132004."},{"key":"1058_CR21","unstructured":"Linacre J. Sample size and item calibration (or person size) stability Rasch Measurement Transactions1994. https:\/\/www.rasch.org\/rmt\/rmt74m.htm."},{"key":"1058_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-33","volume":"8","author":"AB Smith","year":"2008","unstructured":"Smith AB, Rush R, Fallowfield LJ, Velikova G, Sharpe M. Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol. 2008;8:33.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"1058_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"1058_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94\u2013104.","journal-title":"Value Health"},{"issue":"10","key":"1058_CR25","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1212\/WNL.0000000000008063","volume":"93","author":"A Chi\u00f2","year":"2019","unstructured":"Chi\u00f2 A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93(10):e984\u201394.","journal-title":"Neurology"},{"issue":"7","key":"1058_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jnnp-2020-322992","volume":"91","author":"E Beeldman","year":"2020","unstructured":"Beeldman E, Govaarts R, de Visser M, Klein Twennaar M, van der Kooi AJ, van den Berg LH, et al. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91(7):779\u201380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1058_CR27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00415-022-11433-z","volume":"270","author":"E Colombo","year":"2023","unstructured":"Colombo E, Poletti B, Maranzano A, Peverelli S, Solca F, Colombrita C, et al. Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis. J Neurol. 2023;270(2):898\u2013908.","journal-title":"J Neurol"},{"key":"1058_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00192","volume":"10","author":"J Caga","year":"2019","unstructured":"Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E. The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol. 2019;10:192.","journal-title":"Front Neurol"},{"key":"1058_CR29","doi-asserted-by":"publisher","DOI":"10.4135\/9781412985598","volume-title":"Rasch models for measurement","author":"D Andrich","year":"1988","unstructured":"Andrich D. Rasch models for measurement. Thousand Oaks, California: SAGE Publications, Inc.; 1988."},{"key":"1058_CR30","volume-title":"Fundamentals of item response theory","author":"R Hambleton","year":"1991","unstructured":"Hambleton R, Swaminathan H, Rogers H. Fundamentals of item response theory. London: Sage; 1991."},{"issue":"2","key":"1058_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/jnnp.74.2.242","volume":"74","author":"C Jenkinson","year":"2003","unstructured":"Jenkinson C, Norquist JM, Fitzpatrick R. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5). J Neurol Neurosurg Psychiatry. 2003;74(2):242\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3-4","key":"1058_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","volume":"26","author":"P Mehta","year":"2022","unstructured":"Mehta P, Raymond J, Nair T, Han M, Berry J, Punjani R, et al. Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry. Amyotroph Lateral Scler Frontotemporal Degener. 2022;26(3\u20134):290\u20135.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"1058_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.mayocpiqo.2024.07.008","volume":"8","author":"E Engelberg-Cook","year":"2024","unstructured":"Engelberg-Cook E, Shah JS, Teixeira da Silva Hucke A, Vera-Garcia DV, Dagher JE, Donahue MH, et al. Prognostic factors and epidemiology of amyotrophic lateral sclerosis in southeastern United States. Mayo Clin Proc Innov Qual Outcomes. 2024;8(5):482\u201392.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"5","key":"1058_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000516752","volume":"55","author":"CA Brown","year":"2021","unstructured":"Brown CA, Lally C, Kupelian V, Flanders WD. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology. 2021;55(5):342\u201353.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"1058_CR35","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1038\/s41467-022-34620-y","volume":"13","author":"S Opie-Martin","year":"2022","unstructured":"Opie-Martin S, Iacoangeli A, Topp SD, Abel O, Mayl K, Mehta PR, et al. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration. Nat Commun. 2022;13(1):6901.","journal-title":"Nat Commun"},{"issue":"7","key":"1058_CR36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1212\/01.wnl.0000238505.22066.fc","volume":"67","author":"J Montes","year":"2006","unstructured":"Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, et al. Development and evaluation of a self-administered version of the ALSFRS-R. Neurology. 2006;67(7):1294\u20136.","journal-title":"Neurology"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01058-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01058-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01058-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:22:26Z","timestamp":1792567346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01058-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":36,"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01058-z","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"William B. Nowell, Oren Levy, and Nick Patel are employees of Regeneron Pharmaceuticals, Inc., and hold stock in Regeneron Pharmaceuticals, Inc. Nadine McGale, Krystian Przydzial, and Sophie Cleanthous are employees of Modus Outcomes, a THREAD company. Jinsy A. Andrews has served as a consultant for AL-S Pharma AG (data safety monitoring board [DSMB]), Amylyx Pharmaceuticals, Biogen, Cytokinetics, Neurosense Therapeutics, Akava, QurAlis (DSMB), Regeneron Pharmaceuticals, Inc., and Sanofi (DSMB); and has received research funding to their institution from The ALS Association, Biogen, Cytokinetics, Corcept Therapeutics, ALS Platform Trial (Biohaven, Clene Inc., Ra Pharmaceuticals, Prilenia Therapeutics, Calico, Denali Therapeutics, and The Mass General Hospital Foundation), and the\u00a0National Institute of Health\/National Institute of Neurological Disorders and Stroke. Diana Rofail was a full-time employee of Regeneron Pharmaceuticals, Inc. at the time of the study, and holds stock in Regeneron Pharmaceuticals, Inc., and Roche; Dr Rofail is currently an employee of Sanofi, Inc.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Western-Copernicus Group Institutional Review Board\u2019s Affairs Department reviewed the study protocol under the Common Rule and applicable guidance and approved a request for a waiver of authorization for the use and disclosure of protected health information. All participants provided written informed consent to participate and were paid a fee in line with fair market value to cover the time taken to participate in the study. This study is reported in accordance with the Consolidated Criteria for Reporting Qualitative Research guidelines [\n                      \n                      ].","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}